Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance.

E A Earle-Boyer1, M R Serper, M Davidson

  • 1Mt. Sinai School of Medicine, New York, NY 10029-6574.

Psychiatry Research
|April 1, 1991
PubMed
Summary

Schizophrenia patients showed more errors on the Continuous Performance Test (CPT) than controls. Unmedicated patients struggled more with nonlexical stimuli, suggesting medication impacts attention and cognitive functions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asthma.

Postgraduate medical journal·2011
Same author

Ideals in Medical Education.

Postgraduate medical journal·2011
Same author

The Principles and Practice of Medicine.

Postgraduate medical journal·2011
Same author

The task of the practitioner in the tuberculosis problem.

Medical world·2010
Same author

Observations on INTRATHORACIC NEW GROWTHS AND THE VALUE OF BRONCHOSCOPY IN DIAGNOSIS AND TREATMENT.

British medical journal·2010
Same author

Pathogenesis of Bronchiectasis.

British medical journal·2010

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Schizophrenia is associated with cognitive deficits, particularly in attention and executive functions.
  • The impact of antipsychotic medication on cognitive performance in schizophrenia requires further elucidation.
  • Continuous Performance Test (CPT) is a standard tool for assessing sustained attention.

Purpose of the Study:

  • To compare cognitive performance on the CPT in medicated and unmedicated schizophrenia patients versus healthy controls.
  • To investigate the influence of stimulus type (lexical vs. nonlexical) and modality (auditory vs. visual) on CPT performance.
  • To examine the relationship between neuromotor competence and CPT performance in different patient groups.

Main Methods:

  • A comparative study involving medicated schizophrenia patients (n=17), unmedicated schizophrenia patients (n=17), and healthy controls (n=19).

Related Experiment Videos

  • Administration of auditory and visual versions of the CPT with lexical and nonlexical target stimuli.
  • Assessment of neuromotor competence through measures of motor speed and proficiency.

    • Main Results:

    • Healthy controls outperformed both schizophrenia patient groups on all CPT error types.
    • Unmedicated patients exhibited significantly more errors on nonlexical stimuli compared to medicated patients.
    • Motor proficiency correlated with CPT performance in medicated patients, but not in unmedicated patients.

    Conclusions:

    • Medication status significantly influences CPT performance in schizophrenia, particularly concerning nonlexical stimuli processing.
    • Neuromotor function may interact with cognitive performance in medicated schizophrenia patients.
    • These findings highlight the role of antipsychotic medication in modulating specific cognitive and attentional deficits in schizophrenia.